A Month Until #CES2026 – The Journey to Our Personal Health Operating Systems

In a month, I’ll board a plane for Las Vegas to spend a week at CES 2026, the annual electronics conference that last year brought together over 140,000 global technology stakeholders to display, demonstrate, and sell the latest in consumer-facing tech. This will be my fourteenth CES (including the virtually convened meeting held in 2021). If you want to time travel, here’s a link to an early CES post featuring “The Battle of the (Wrist)bands.” Indeed, the digital health aisle at the time had many wrist-worn activity trackers, largely amped-up pedometers, with the likes
Where Health Meets Beauty, Mental Health, and Faith: Learning from the Farmaceutica di Santa Maria Novella

What is a pharmacy? And what are “medicines?” I’ve been thinking about this question for some time, and had the opportunity to consider this in real-time in a sort of back-to-the-past-to-the-future moment when I spent time at the glorious Farmaceutica of Santa Maria Novella (SMN) in Florence, Italy (in longhand, the “Officina Profumo-Farmaceutica di Santa Maria Novella)” on 8th November. This meet-up at this 800+ year old institution is one of many touchpoints in my work and personal life between late October and late November, where I’m working on health/care issues in 4 Euro cities: starting with London in week
As SNAP Benefits Were Threatened to be Cut in the U.S., Eli Lilly’s Obesity Drugs Rose to the World’s Best-Selling Drug

Today, 1 November, the Supplemental Nutrition Assistance Program (SNAP) was to be shuttered and unfunded in at least 25 states until the U.S. Congress agreed to re-open the Federal government and fund this safety net for food security that covers 42 million people in America. Those 42 million people included 16 million children, about 39% of SNAP program beneficiaries. Then last night, a Federal judge intervened to order President Trump’s administration to reinstate funding for food assistance just-in-time. At this moment, I cannot tell you what the exact timing nor the amounts beneficiaries will receive will be.
Paging Dr. Verily – What Consumers Want from Health Tech: Personalization, Control, Privacy, and Ease

“What do consumers want from their health technology?” wondered a poll conducted among smartphone-owning health care decision makers. Greater control and engagement in health care, assurance of privacy and security for their health data. and greater personalization of advice coming out of the analysis of that shared personal health information. Welcome to the Consumer Survey on Personal Health Technology, market research conducted by Verily with The Harris Poll among 2,000 U.S. adults 18 and older in July 2025. The screening criteria used to include a survey respondent were two-fold: whether they owned a smartphone, and made the majority of their
In 10 Years, Health Care Will Happen Where Life Happens – PwC’s Tea Leaves into 2035

The costs of medical care are breaking the system, PwC asserts at the start of its new report on the $1 trillion opportunity to reinvent healthcare. The past 3 years of 8+% U.S. national health expenditure increases are “untenable,” PwC says, with 90% of that spending going toward patients with chronic and mental health conditions. What will transform the system and move us from “breaking point to breakthrough?” Biology and technology, PwC explains, with technology moving exponentially and simplifying care at scale, and biology decoding the “human operating system” enabling precision at scale. This
Expect Double-Digit Prescription Drug Trend Increases in 2026 – The Update from HUB International

Prescription drug price trend for 2026 will be between 10% and 12% according to the 2026 Trend Study from HUB International, a global insurance and financial services firm. Here’s HUB’s line chart of the combined medical and Rx trend, illustrating nearly double trend growth since 2022 following the peak of 10.1% (combined) in 201 as patients returned to health care services and encounters when feeling safe in the fading out of the COVID-19 pandemic. That precipitous low-point in 2022 of 3.4% was the peak of the coronavirus stay-at-home period, representing the “medical distancing” felt across
Prescription Drug Pricing in America – a 3-Part Update, From the Over- the-Counter OPill and “Half-Price” Ozempic to Most-Favored-Nation Rx (Part 3)

Welcome to Part 2 of 3 in my consideration of Prescription Drug Pricing in America. You can catch up with yesterday’s Part 1 post here, and Part 2 here. The macro-context for these 3 posts are the forecasts for health care spending for the coming year. Health care cost increases forecasted for 2026 will, in significant part, be driven by prescription drug trend. This graphic from this week’s release of the Business Group on Health’s employer survey on healthcare cost growth to 2026 illustrates a key finding that’s echoed in other similar studies recently released and covered here in Health Populi.
Prescription Drug Pricing in America – a 3-Part Update, From the Over- the-Counter OPill and “Half-Price” Ozempic to Most-Favored-Nation Rx (Part 1)

Health care costs will increase, overall, as much as 10% in 2026, the consensus of several health benefit analysts inform us. And, “workers to bear brunt of health cost increases in 2026,” reads today’s Axios headline on the topic, weaving together several studies from the Business Group on Health, Mercer, and the International Foundation of Employee Benefit Plans. A kay cost-contributor cited in all of these health cost forecasts is the prescription drug line item: specialty drug prices, and specifically the costs of GLP-1 medicines and cancer therapies. One strategy gaining fast-traction on both the
What U.S. Consumers Are Thinking About Tariffs’ Impacts on Health Care: Looking to Ipsos, QCentrix and Goldman Sachs

Most Americans, thinking as health consumers, believe that tariffs could impact peoples’ ability to pay for costly prescription drugs and be priced out of paying for check-ups and medical supplies, based on results from two studies on consumers’ views on tariffs and their health care from Ipsos and Q-Centrix. Ipsos’s consumer survey found that younger consumers, people earning lower incomes, and folks living in the suburbs feel even more stressed about tariffs’ impact on medical care — along with more people identifying as Democrats or Independent voters. With
Ozempic: A Medicine, and a “Cultural Shorthand” – What The Harris Poll Knows About Gen Z Consumers and Health Care in America

Among the top 20 fastest-growing growth brands beloved by Americans between 18 and 28 years of age — that is, Gen Z consumers — we see brand-equity love for companies channeling athleisure, fashion, new-fangled financial products, and food & beverage brands. And then there’s Ozempic, which gained 10 full percentage points from Q1-2025 to Q2-2025, according to The Harris Poll’s QuestBrand research. What does it mean that a prescription drug has joined these brand-loved rankings? The QuestBrand research found that as of the second quarter of 2025, more than one in 3
Why a Grocery Store Signed On to “Make Health Tech Great Again”

Joining the ranks of technology heavyweights Amazon, Anthropic, Apple, Google, and OpenAI, as well as digital health innovators Noom, Oura, Virta Health and Welldoc, who have pledged to “Make Health Tech Great Again,” Albertsons, one of the largest grocery chains in the U.S., put its name on the list with these and other early adopter collaborators. The Albertsons’ company blog published on 31 July discussed the background and rationale for this decision. “Specifically, we pledge to explore how our Sincerely Health platform can connect to The Centers for Medicare and Medicaid Services (CMS) Aligned
The Patient as Consumer – Updates from Fidelity on Retiree Health Care Costs ($172,500), Delaying Care, Tariff Impacts on Spending, and Roche Going DTPatient for Rx’s?

As of August 2025, U.S. patients of all demographics and geographies face many uncertainties with respect to their care. Issues such as health plan coverage, prescription drug costs, and access to services, among other challenges, continue to re-shape patients-as-health-consumers seeking transparency, clinical choices, and trust-worthy relationships with touchpoints in their personal health ecosystems. Four just-breaking stories across the health/care ecosystem illustrate several of these uncertainties and forces in U.S. health care — some adding friction and angst in a patient’s life, others perhaps providing some relief for certain health consumers. These news items address health care costs in retirement, the
Medicare at 60: Prior Authorizations Are a Problem for People in the U.S., Regardless of One’s Political Party, Income, or Insurance Type
Happy 60th Anniversary Medicare, today marking six decades since the passage of this law which was a landmark milestone for The Great Society, U.S. style. Since its inception and implementation, Medicare quite often leads in adoption of new medicines, new processes, new technologies in health care. But as I track the phenomenon of health citizenship in the U.S., I observe growing consensus among American patients — cross health plan type — increasingly impatient for health care access. We can now add Americans’ growing dissatisfaction with the prior authorization process, an opinion that now spans majorities of consumers regardless of their
Most People Would Choose Food Over Meds to Get Healthy. But Barriers to Consumers Doing So Will Require Collaborative Approaches That Get Closer and Personal

The pandemic era re-shaped consumers’ views on food as an input for health across all dimensions. We look back with affection for our local grocery stores and pharmacies which played leading roles as first responders f0r our health and, quite literally, the basic needs at the base of our personal hierarchies the way Maslow conceived them. As I tracked home-bound consumers’ behaviors from the start of COVID-19 in March 2020, I hunted-and-gathered data from Nielsen, Acosta, Circana, Gallup, Harris, and other sources of consumers @ retail. The DIY food-health concept, coined by Nielsen, was the build-up of our “pandemic pantries.”
U.S. Workers Who Get Health Insurance From Work Can Expect Greater Cost-Sharing and New Networks in 2026

At least one-half of employers will likely raise employee cost-sharing amounts in 2026, according to the Survey on health & benefit strategies for 2026 from Mercer. Mercer surveyed 711 organizations for this study, fielded in April 2025, to assess employers’ views on and strategies for health benefits in 2026. There are three challenging pillars underlying employers’ 2026 approaches to workers’ benefits: How to disrupt cost growth with what Mercer coins as “bolder” strategies How to consider and address all dimensions of affordability, and, How to design and implement inclusive benefits that build workforce
Medical Cost Trend at 8.5% in 2026? PwC Sees “No End in Sight” for Increased Healthcare Spending

For the third year in a row, medical cost trend — the expected increase of health care costs by health plans — will be 8.5% for group health insurance. This contrasts with a low of 5.5% in 2022 when cost trend dipped coming out of the COVID-19 pandemic….then shot up to 8.0% the following year in patients’ healthcare catch-up mode. Welcome to Behind the Numbers 2026, the annual medical trend report from PwC. What’s continuing to drive up health care costs? PwC identifies 4 medical cost inflators, and 2 “deflators” (these being
Consumers Look to Brands to Both “Do Good” and Help Me “Feel Good” – Another Riff on the Edelman Trust Barometer and What This Means for Health Care

With consumers the world over feeling greater financial stress and social chasms in 2025, people are trusting brands more than institutions to help them both feel good and expecting them to “do” good, we learn in Brand Trust, From We to Me, a special report from the 2025 Edelman Trust Barometer. The overall theme of this year’s Trust Barometer was “Trust and the Crisis of Grievance.” One artifact of peoples’ grievance is their shift from “we” to “me;” in this new report with a lens on brands, Edelman finds that consumers expect
National Health Spending in the U.S. in 2033: What 20.3% of the GDP Will Be Spent On

By 2033, national health spending will comprise 20.3% of the U.S. GDP, based on the latest national health expenditure projections developed by researchers from the Centers for Medicare and Medicaid Services (CMS). This growth will be happening as CMS projects coverage of insured people to decline over the period. Earlier today, I attended a media briefing hosted by Health Affairs to receive the CMS team’s top-line forecast of NHE from 2024 to 2033 discussing these findings. Fuller details on the projections will be released in the July issue of Health Affairs on 7
Consumers’ Favorite Brands for 2025 Look a Lot Like Pandemic Times: All About Hygiene, Safety, Personal Care, and Packages

Shades of the year 2020; it’s déjà vu all over again when it comes to consumers’ most trusted brands in 2025 featured in Morning Consult’s Most Reputable Brands report. Here’s the list of the top 25 most trusted brands across all consumer touch-points and industries for all adults, ages 18 and older. A quick calculation reveals that consumers most trust brands covering, Home keeping and hygiene – Dawn, Clorox, Lysol, Mr. Clean, Home Depot Self- and personal care – Dove, Oral-B, Kleenex, Colgate Health – BAND-AID, Tylenol Packages
What GoFundMe and Crowdfunding Campaigns Tell Us About Healthcare in America

“Can people afford to pay for health care?” a report from the World Health Organization asked and answered, with a focus on European health citizens. The same question underpins a new research paper published in Health Affairs Scholar, Insights from crowdfunding campaigns for medical hardship, Here, crowdfunding is a proxy for “can’t afford to pay for health care” in America. Here in blazing colors we have a snapshot of the study’s data in the form of a “heatmap.” FYI, a heatmap is a data visualization format that represents the magnitude of values of a dataset as a color — generally
We Go Further Together: Calling for Collaborations, An Actionable Context for AHIP 2025

There are many ways to measure the dysfunction of health care in the U.S.: we can point to relatively poor incomes relative to the rest of the developed world, given how much money is allocated to health care in America. The maternal mortality rate in the U.S. is unconscionably high, akin to some middle- and lower-income nations in the world. And medical debt is a uniquely American form of financial toxicity compared with other OECD nations where the concept is, well, foreign. Even with these many failures, though, it’s important to put U.S. health care in a larger context: the
A Toyota RAV4 Hybrid, a Playground Set, or Healthcare for a Family of 4: What $35,119 Can Buy in 2025 According to Milliman
If you went shopping for something that cost $35,119 in 2025, which would you most value? A new 2025 Toyota RAV4 Hybrid with some extras on board? A Canyon BYO playground set for your yard, school, or social-athletic club? Or, Healthcare coverage for a family of 4 in the form of a PPO? Welcome to this year’s 20th anniversary edition of the Milliman Medical Index (MMI), which I’ve looked forward to reviewing for most of its two-decade history. [You can read my annual takes on the MMI here in Health Populi by searching “MMI” and the year of publication in
Marketing Women’s Health: How Organon’s Nexplanon Took a Page Out of Romance Novels

With women’s health and femtech investing in the spotlight in 2025, most of the focus has been on either women’s access to health care services (e.g., for abortion and prenatal/primary care) to start-ups focusing on fertility technology and benefits, along with growing awareness of the long-overlooked menopause market opportunity. Contraception? Not so visible. Of course, we welcomed the Opill to the over-the-counter medicines market last year with FDA approval of the switch to retail pharmacy and vending machine access. Now let me point you to a newfangled marketing campaign for
If Food Is Medicine, Some Might Feel It’s a Luxury Good Like a Specialty Drug

Most people in the U.S. say it’s harder to eat healthy given the cost of “healthy food,” we learn in the report on Americans on Healthy Food and Eating from the Pew Research Center, published 7 May 2025. With a view that healthy food is “too expensive,” it may feel like aspiring for it feels like luxury-good shopping, or being a patient prescribed a specialty (high-cost) drug. The Pew team polled 5,123 U.S. adults’ perspectives on eating, fielded between 24 February and 2 March 2025. This report is timely as Secretary of Health and
How Consumers’ Economic Sentiments Are Shaping Peoples’ Financial and Emotional Well-Being (Spoiler: Not So Good): Learning from CivicScience

When it comes to health, the words “fiscal” and “physical” are morphing as peoples’ economic feelings (the “fiscal”) are shaping physical and emotional health, we find in U.S. consumer data presented by John Dick, Founder and CEO of CivicScience. The Consumer Technology Association convened a special session with John, who painted a portrait of the U.S. consumer at a point in time — late April 2025 — reminding us more than once during the hourlong session that, “Everything is constantly changing.” One certainty that we can be sure of, in the dismal-scientist way
Loneliness As Risk Factor for Health and Medication Adherence

The role of loneliness and social isolation plays into every aspect of human health, beyond mental and behavioral impacts: loneliness is a risk factor for overall health status and well-being, as well as a barrier to medication adherence, we learn in Loneliness and Health Behaviors: A Missing Link in Chronic Care from Pleio. Pleio launched the report at the Assembia AXS25 Conference in Las Vegas yesterday, Pleio surveyed 2,008 U.S. adults in March 2025 living with at least one chronic condition to gauge patients’ perspectives on loneliness, health outcomes, and peoples’ adherence to prescribed medicines.
U.S. Health Care in 2025 Requires Scenario Planning: The Uncertainties (AI!?) That Inspire DIY Healthcare

As Weight Watchers prepares to initiate bankruptcy proceedings, I file the news event under “thinking the unthinkable.” “Thinking about the unthinkable” is what Herman Kahn, a father of scenario planning, asked us to do when he pioneered the process. In this book, for Kahn, “the unthinkable” was thermonuclear war, and the year was 1962. The book was tag-lined as “must reading for an informed public” and in it, Kahn I’ve been drawn back to this book lately because of a more intense workflow using
Are We Liberated Yet? Tariffs Can Impact Financial Health (Riffing on MoneyLion’s Health Is Wealth Report)

Americans’ financial health was already stressing consumers out leading up to Liberation Day, April 2nd, when President Trump announced tariffs on dozens of countries with whom the U.S. buys and sells goods. A new report from MoneyLion and Mastercard called Health is Wealth is well-timed for today’s Health Populi blog. The study was fielded by The Harris Poll online among 2,092 U.S. adults 18 and older between February 28 and March 4, 2025, so it was completed a month before the tariffs came to hit peoples’ 401(k) savings and employers’ company stock market caps.
How BioPharma Can Improve Consumers’ Experience and Health

Patients as health consumers now know what “good” looks like in their digital experiences. People have tasted the convenience and respect they feel from well-designed, streamlined omnichannel retail experiences, and they now expect this from health care — specifically supported by the pharmaceutical companies who manufacture the medicines they use in managing chronic conditions, we learn in ixlayer ixInsights 2025: Pharma’s Role in Improving the Health Experience from ixlayer and Ipaos. The patient-focused report gets specific about people dealing with asthma, COPD, Type 2 diabetes, heart disease, psoriasis, and atopic dermatitis with a lens on
What is a Consumer Health Company? Riffing Off of Deloitte’s Report on CHCs/A 2Q2025 Look at Self-Care Futures

The health care landscape in 2030 will feature an expanded consumer health industry that will become, “an established branch of the health ecosystem focused on promoting health, preventing, disease, treating symptoms and extending healthy longevity,” according to a report published by Deloitte in September 2024, Accelerating the future: The rise of a dynamic consumer health market. While this report hit the virtual bookshelf about six months ago, I am revisiting it on this first day of the second quarter of 2025 because of its salience in this moment of uncertainties across our professional and personal lives — particularly related to
Art Collides with Health Policy: When “When Calls the Heart” Met MAHA This Week

Art reflects life — or in this case, bumps into life and health care — once again when the pop culture facet of my own media consumption converges with a news announcement where the timing of these events is just too uncanny. It never occurred to me I’d ever write about the Hallmark Channel in the Health Populi blog. But reading the news that President Trump’s administration plans to cut funding for the ongoing 30-year study into diabetes and pre-diabetes — the landmark National Diabetes Prevention Program (NDPP) — dovetailed (or perhaps more honestly stated, collided) with the plotline of
The Top Patient Safety Risks in 2025 Are Mostly About the “Human OS” – Reading ECRI’s Annual Report

Each year, ECRI (the ECRI Institute) publishes an annual report on the Top 10 Patient Safety Concerns for the year. The 2025 list was published today. My read of it is that most of these risks have to do with what I’ve been referring to as the Human OS, the Human Operating System, in my talks and teachings. In this post, I’ll focus on 2 of the 10 most top-of-mind in my current workflow with clients and speaking: #1 and #3. Here’s the list of 10, calling out: Risks of dismissing
Consumers Are Financially Stressed – What This Means for Health/Care in 2025

People define health across many life-flows: physical health, mental health, social health, appearance (“how I look impacts how I feel”) and, to be sure, financial well-being. In tracking this last health factor for U.S. consumers, several pollsters are painting a picture of financially-stressed Americans as President Trump tallies his first six weeks into the job. The top-line of the studies is that the percent of people in America feeling financially wobbly has increased since the fourth quarter of 2024. I’ll review these studies in this post, and discuss several potential impacts we should keep in mind for peoples’ health and
GLP-1s at the Pharmacy – A Lens on Consumer-Driven Retail Health (with Hims & Hers stock price update)

The nature of retail pharmacy is changing, with both threats and opportunities re-shaping the business itself, and the pharmacy’s role in the larger health/care ecosystem. To keep sharp on the topics, I attended Rx Market Insights: Performance Trends and Outlook for 2025, a data-rich session presented on February 18 by IQVIA and sponsored by Ascend Laboratories. The webinar was hosted by DSN (Drug Store News), appropriately so because the action-packed hour went into detail providing the current state of prescription drugs and the pharmacy in America. Doug Long, IQVIA’s VP of Industry Relations, and Scott Biggs, the company’s Director of Supplier
Health/Care at Super Bowl LIX, GLP-1s, Kaiser and Tufts on Food-As-Medicine, and the RFK, Jr. Factor: A Health Consumer Check-In

In the wake of the always-creative ads for Super Bowl and last Sunday’s LIX bout, game-watchers got to see a plethora of commercials dedicated to the annual event’s major features: food and game-day eating. Oh, and what’s turned out to be the most controversial commercial, the one on GLP-1s from Hims & Hers. In that vein, and converging with many news and policy events, I’m trend-weaving the latest insights into that most consumer-facing of the social determinants of health: food, and in particular, health consumers viewing and adopting food as part of their health and well-being moves. First, to the
Measuring Progress for Life Sciences: Trust, Patient Access, and Prevention at a Fork in the Road of Public Health

How will we know if the life sciences sector is advancing in 2025? This is the question asked at the start of the report, a Research Brief: 2025 Indicators of Progress for the Life Sciences Sector, from the IQVIA Institute for Human Data Science (IQVIA). To answer that question, IQVIA identified ten indicators for this 2025 profile on the life sciences sector. I selected four key data points for this discussion which provide particularly informative insights for my advisory work right now at the intersection of health, people/consumers, and technology: Trust for/with/in life science
How Disrupting the Generic ED Meds Sales Model Marries to Our Digital Coexistences – Mark Cuban at the Shelly Palmer Innovation Series Breakfast #CES2025

What was Mark Cuban doing “gate-crashing” Shelly Palmer’s Innovation Breakfast? My worlds of content and health care collided in a serendipitous way this morning when, at the conclusion of my annual beloved experience attending and learning at the Shelly Palmer Innovation Series breakfast which focuses on content, media, entertainment, and now AI mashing up everywhere, all at once, Mark Cuban appeared as a late-breaking guest in fireside chat with Shelly. Here’s my photo to prove it, circa 903 am this morning. Before even chatting about AI, X, and his
How GLP-1s Are Showing Up at CES 2025

CES 2025: as you read the acronym and year, your brain registered an image like consumer technology and the start of a new year, or some variation of those thoughts. When you saw the title of this post with the acronym “GLP-1,” your brain might not have connected the dots between a medicine and “CE,” consumer electronics. But here we are in real-time, in real life, at the convergence of pharmaceuticals and medicines and consumer-facing technology. And keep in mind that we’re at the annual meeting of CES which is convened by the Consumer Technology Association, CTA. GLP-1s are showing
The Rough Guide to Health/Care Consumers in 2025: The 2025 Health Populi TrendCast

At this year-end time each year, my gift to Health Populi readers is an annual “TrendCast,” weaving together key data and stories at the convergence of people, health care, and technology with a look into the next 1-3 years. If you don’t know my work and “me,” my lens is through health economics broadly defined: I use a slash mark between “health” and “care” because of this orientation, which goes well beyond traditional measurement of how health care spending is included in a nation’s gross domestic product (GDP); I consider health across the many dimensions important to people, addressing physical,
National Healthcare Spending in the U.S. Was Nearly $5 Trillion (with a “T”) in 2023 – New Data from CMS

What would $5 trillion be valued around the world or on the stock market? The economy of Germany was gauged around $5 trillion in 2024. India could be the world’s 3rd largest economy by 2026 valued at $5 trillion. Nvidia could be a $5 trillion company in 2025, as could Amazon. But today we report out the latest data from the Centers for Medicare and Medicaid Services (CMS) that national health spending in America reached $4.9 trillion in 2023. The full report on national health expenditures (NHE) in the U.S. was published today in Health Affairs, which came off embargo
How World AIDS Day 2024 Can Inform Healthcare in 2025

December 1 2024 was World AIDS Day, which was observed by the Biden White House with the display of the entire AIDS Memorial Quilt on the South Lawn — all 54 tons of it. The Biden-Harris Administration announced efforts, in advance of World AIDS Day, to continue to fight HIV/AIDS “at home and abroad.” The press release for the effort noted that, ”We remember those who have died from AIDS-related illnesses—honoring their courage and contributions as essential to the progress made thus far. We also stand in solidarity with the more than 39 million people with HIV around the world.
Workers Feel “Stuck,” Under-Insured, Financially Stressed, and Neglecting Mental Health

“It’s the economy stupid,” Jennifer Tescher, CEO of the Financial Health Network, titles her latest column in Forbes. Published two weeks after the 2024 U.S. elections, Jennifer’s assertion sums up what, ex post facto, we know about what most inspired American voters at the polls in November 2024: the economy, economics, inflation, the costs of daily living….pick your noun, but it’s all about those Benjamins right now for mainstream American consumers across many demographic cuts. With that realization, we must remind ourselves as we enter a new year under a second-term President Trump that health care spending for everyday people
3 in 4 U.S. Patients Say the Healthcare System is Broken — But Technology Can Help

Patients “yearn” for personalized services and relationships in health care — optimistic that technology can help deliver on that hope — we learn in Healthcare’s Future: Balancing Progress and Perception, a health consumer survey report from Lavidge. Lavidge, a communications/PR/marketing consultancy, polled U.S. patients’ attitudes about health care and technology in June 2024, publishing the report earlier this month. Start with over-arching finding that, “Three out of four patients believe the U.S. healthcare system is broken and there is a strong sense of distrust,” Lavidge asserts right at the top of
What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices

For health care, there are many uncertainties as we reflect, one week after the 2024 U.S. elections, on probably policy and market impacts that we can expect in 2025 and beyond. In today’s Health Populi post, I’ll reflect on the first of several certainties we-know-we-know about U.S. health citizens and key factors shaping the American health ecosystem. In this first of several posts on “What Stays True for U.S. Health Care Post #Election2024,” I’ll focus on U.S. consumer dissatisfaction with drug prices — across political party identification. Let’s set the context with data from a recently-published
Health Care Costs and Access On U.S. Voters’ Minds – Even If “Not on the Ballot” – Ipsos/PhRMA

Today marks eight days before #Election2024 in the U.S. While many political pundits assert that “health care is not on the ballot,” I contend it is on voters’ minds in many ways — related to the economy (the top issue in America), social equity, and even immigration (in terms of the health care workforce). In today’s Health Populi blog, I’m digging into Access Denied: patients speak out on insurance barriers and the need for policy change, a study conducted by Ipsos on behalf of PhRMA, the Pharmaceutical Research and Manufacturers of America — the pharma industry’s advocacy organization (i.e., lobby
The Health Insurance Premium for a Family Averages $25,572 in 2024 – KFF’s Annual Update on Employer-Sponsored Benefits

The premium for employer-sponsored health plans grew by 6-7% between 2023 and 2024, according to the report on Employer Health Benefits 2024 Annual Survey from the Kaiser Family Foundation, KFF’s 26th annual study into U.S. companies’ spending on workers’ health care. In 2024 the average annual health insurance premium for family coverage is $25,572, split by 75% covered by the employer (just over $19,000) and 25% borne by the employee ($6,296), shown in the first chart from the report. The nearly $26K family premium is the average across all plan types in the
Americans’ Perspectives on Pharma and Healthcare Industries Are Low and Low-Ish Compared with Most Other Sectors

Only 20% of U.S. adults have a positive view of the pharmaceutical industry, garnering the lowest positive vibes among Americans in Gallup’s latest survey on peoples’ opinions of industries in America. About 1 in 3 Americans feel positively about health care in the U.S., on par with publishing and the electric/gas industries — on the lower end of these findings. By far, the top-perceived industry in the U.S. is agriculture and farming, taking the first spot with 64% of Americans’ positive views. Restaurants and the computer sector get 52% positives, although Gallup points out
Obesity is a Public Health Epidemic in the U.S. — The Case for GLP-1 Coverage, Affordability and Equity

“If the U.S. were sensible, weight management would be treated as a public health issue,” David Cutler writes in the JAMA Health Forum dated August 15, 2024. Dr. Cutler, distinguished economics professor at Harvard, talks about “the pathology of U.S. health care” citing the example of weight loss medications — in short, the uptake of GLP-1 drugs to address Type 2 diabetes first, and subsequently obesity. Dr. Cutler notes that the price of these drugs in the U.S. “far exceeds” that of other countries: specifically, 9 times that of the prices in Germany and the Netherlands
Where Democrats and Republicans Agree on Health Care Policies – From Medicare and Prescription Drugs to Gun Safety

In a super-divided electorate like the U.S. with about 60 days leading up to the 2024 Elections, we might assume there are no “purple” areas of agreement between the Red (Republicans) and the Blue (Democrats) thinking in PANTONE color politics. Surprisingly, there are many health policies on which Democrats and Republicans concur, as found in a series of YouGov polls conducted in May 2024. YouGov fielded the health policies poll in five waves online, each among roughly 1,100 U.S. adults in May 2004. This bar chart summarizes health
How Voting Plays Into Health, Health Equity, and Community Well-Being

“Voter registration in hospitals is the new frontier in health care.” That’s the headline in a WBUR story last week detailing the efforts of health care professionals in “amplifying” their patients’ voices inside and outside of the hospital walls by advocating for their health citizenship — through voter registration and public health policy advocacy. I’m a long-time evangelist for health citizenship and the role that a person’s engagement in the civic commons plays in one’s own health, the health of their communities and of the nation as a whole. I’m not alone
Women’s Health Outcomes in the U.S.: Spending More, Getting (Way) Less – 4 Charts from The Commonwealth Fund

Women in the U.S. have lower life expectancy, greater risks of heart disease, and more likely to face medical bills and self-rationing due to costs, we learn in the latest look into Health Care for Women: How the U.S. Compares Internationally from The Commonwealth Fund. The Fund identified four key conclusions in this global study: Mortality, shown in the first chart which illustrates women in the U.S. having the lowest life expectancy of 80 years versus women in other high-income countries; Health status, with women in the U.S. more likely to consume multiple prescription
Retail Health Update for Pharmacy – Mail Order Beats Brick & Mortar, J.D. Power Finds

People have been undergoing their own human kind of digital transformations, turbocharged during the pandemic for many who never used Zoom or Amazon Prime or Uber. That consumer-borne digital transformation has shaped people as health consumers, many having used telehealth and appointment-scheduling online. And peoples’ relationships with pharmacies are also changing, with more health consumers finding greater satisfaction with their mail order pharmacy experiences than with moat retail brick and mortar chain drug stores, the latest J.D. Power 2024 U.S. Pharmacy Study found. It’s clear that mail order is
Older Americans Mostly Receptive to Apps for Health, but Chronically Ill People Could Use a Nudge (and a Payer)

AARP found that 7 in 10 people ages 50+ are “app-receptive” for health and wellness apps in Unlocking Health and Wellness Apps: Experiences of Adults Age 50-Plus, a summary of research conducted with U.S. consumers 50 and over from AARP. The methodology for this study included only older consumers who were comfortable in downloading apps to smartphones or tablets, and were willing to do so — whom AARP considered the target audience for this research. In addition, the respondents surveyed were also at least interested in trying apps designed for health and wellness, thus dubbed “health
What’s Expected to Drive Up Health Plan Costs in 2025: GLP-1s, Behavioral Health, and Inflationary Pressures for Hospitals and Doctors – PwC’s Behind the Numbers 2025

The U.S. Bureau of Labor Statistics had good news for American consumers long-facing inflation for household spending over the past couple of years, announcing on July 11, 2024, that the general consumer price index (CPI) fell, lowering real prices for people buying airline tickets, used cars and trucks, communication, and petrol to fill auto tanks. That positive economic news did not extend to medical care and personal care, the BLS reported, whose costs increased by 3.3% and 3.2%, respectively. (Motor vehicle insurance costs grew a whopping 19.5% in the report, FYI). Following the
Medical Debt, Aflac on Eroding Health Benefits, the CBO’s Uninsured Forecast & Who Pays for Rising Health Care Prices: A Health Consumer Financial Update

On June 11, Rohit Chopra, the Director of the Consumer Financial Protection Bureau (CFPB) announced the agency’s vision to ban Americans’ medical debt from credit reports. He called out that, “In recent years, however, medical bills became the most common collection item on credit reports. Research from the Consumer Financial Protection Bureau in 2022 showed that medical collections tradelines appeared on 43 million credit reports, and that 58 percent of bills that were in collections and on people’s credit records were medical bills.” Chopra further explained that medical debt on a consumer credit report was quite different than other kinds
Most Americans Follow an Eating Pattern in Search of Energy, Protein, and Well-Being – With Growing Financial Stress: A Food as Medicine Update

Most Americans follow some kind of eating regime, seeking energy, more protein, and healthy aging, according to the annual 2024 Food & Health Survey published this week by the International Food Information Council (IFIC). But a person’s household finances play a direct role in their ability to balance healthful food purchases and healthy eating, IFIC learned. In this 19th annual fielding of this research, IFIC explored 3,000 U.S. consumers’ perspectives on diet and nutrition, trusted sources for food information, and new insights into peoples’ views on the GLP-1 weight-loss drugs and the growing sense
Most Americans, Both Younger and Older, Worry About the Future of Medicare and Social Security

You would assume that most people over 50 would be worried about the financial future of Medicare to cover health care as those middle-aged Americans age. But a surprising two-thirds of young Americans between 18 and 29, and 7 in 10 between 30 and 39 years of age, are concerned that Medicare’s solvency will worsen leading to their not being able to receive Medicare when eligible to receive it, discovered in the 2024 Healthcare in America Report from West Health and Gallup. This year’s research focused on aging in America, exploring areas of U.S. health care system successes as well
A 2025 Subaru Forester, a Year at U-New Mexico, or a Health Plan for a Family of Four: the 2024 Milliman Medical Index

Health care costs for an “average” person covered by an employer-sponsored PPO in the U.S. rose 6.7% between 2023 and 2024, according to the 2024 Milliman Medical Index. Milliman also calculated that the largest driver of cost increase in health care, accounting for nearly one-half of medical cost increases, was pharmacy, the cost of prescription drugs, which grew 13% in the year. The big number this year is $32,066, which is the cost of that employer-sponsored PPO for a family of 4 in 2024. I’ve curated the chart of the MMI statistic for many
Grocers, Food Retailers and Retail Pharmacies Prioritizing Wellness and Health in 2024

Thanks to Progressive Grocer’s 91st annual report and research therein, we have fresh insights into where wellness and nutrition fit into food retailers’ — and pharmacies’ and Big Box stores’ — strategies. That priority ranks high in grocers’ plans for in-store services in 2024 and beyond. Far above all other strategies for food retailers’ in-store services, we see that on-site butchers rank high — among 3 in 4 retailers. Why this might be the case: cost- and value-focused consumers often have questions about how to cook different (lower-priced) costs of meat, or desire
Prescriptions Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA’s 2024 Update

In the past year, the growth of prescription drug utilization and spending has much to do with the use of GLP-1 agonists to treat diabetes and obesity, along with immunology therapy, and lipid meds, along with specialty medicines now accounting for over half of spending — up from 49% in 2018. This update comes from The Use of Medicines in the U.S. 2024 from the IQVIA Institute for Human Data Science. The annual report details trends in health services utilization, the use of prescription drugs, patient financing of those costs, the drivers underpinning the medicines spending, and an outlook to 2028.
The Cost of Medical Care, Long-Term Care, and Prescription Drugs Top Older Americans’ Health-Related Concerns – With Social Security and Medicare Top of Mind

Among Americans 50 years of age and over, the top health-related concerns are Cost, Cost, and Cost — for medical services, for long-term and home care, and for prescription medications. Quality of care ranks lower as a concern versus the financial aspects of health care in America among people 50 years of age and older, as we learn what’s On Their Minds: Older Adults’ Top Health-Related Concerns from the University of Michigan Institute for Healthcare Policy and Innovation. AARP sponsors this study, which is published nearly every month of the year on the Michigan Medicine portal.
Healthcare 2030: Are We Consumers, CEOs, Health Citizens, or Castaways? 4 Scenarios On the Future of Health Care and Who We Are – Part 1

In the past few years, what event or innovation has had the metaphorical impact of hitting you upside the head and disrupted your best-laid plans in health care? A few such forces for me have been the COVID-19 pandemic, the emergence of Chat-GPT, and Russia’s invasion of Ukraine. That’s just three, and to be sure, there are several others that have compelled me to shift my mind-set about what I thought I knew-I-knew for my work with organizations spanning the health care ecosystem. I’m a long-time practitioner of scenario planning, thanks to the early education at the side of Ian
Considering Equity and Consumer Impacts of GLP-1 Drugs – A UBS Economist Weighs In

Since the introduction of GLP-1 drugs on the market, their use has split into two categories: for obesity and “recreationally,” according to the Chief Economist with UBS (formerly known as Union Bank of Switzerland). Paul Donovan, said economist, discusses The economics of getting thin in his regularly published comment blog. “These different uses have different economic consequences,” Donovan explains: Obese patients who use GLP-1s should become more productive employees, Donovan expects — less subject to prejudice, and less likely to be absent from work. While so-called recreational GLP-1 consumers may experience these
The Self-Prescribing Consumer: DIY Comes to Prescriptions via GLP-1s, the OPill, and Dexcom’s CGM

Three major milestones marked March 2024 which compel us to note the growing role of patients-as-consumers — especially for self-prescribing medicines and medical devices. This wave of self-prescribed healthcare is characterized by three innovations: the Opill, GLP-1 receptor agonists, and Dexcom’s Continuous Glucose Monitoring (CGM) system that’s now available without a prescription. Together, these products reflect a shift in health care empowerment toward patients as consumers with greater autonomy over their health care when the products and services are accessible, affordable, and designed with the end-user central to the value proposition and care flows. Let’s take a look at each
The Women’s Health Gap Is Especially Wide During Her Working Years – Learning from McKinsey, the World Economic Forum, and AARP in Women’s History Month

There’s a gender-health gap that hits women particularly hard when she is of working age — negatively impacting her own physical and financial health, along with that of the community and nation in which she lives. March being Women’s History Month, we’ve got a treasure-trove of reports to review — including several focusing on health. I’ll dive into two for this post, to focus in on the women’s health gap that’s especially wide during her working years. The reports cover research from the McKinsey Health Institute collaborating with the World Economic Forum on
Americans Come Together in Worries About Medical Bills, the Cost of Health Care, and Prescription Drug Costs
In the U.S., national news media, Federal statistics, dozens of business leaders and the Federal Reserve Bank have been talking about an historically positive American economy on a macro level. But among individual residents of the U.S., there is still a negative feeling about the economy in a personal context, revealed in the Kaiser Family Foundation Health Tracking Poll for February 2024. I’ve selected three figures of data from the KFF’s Poll which make the point that in peoples’ negative feelings about the national economy, their personal feelings about medical costs rank high
People With Medical Debt Are Much More Likely to Be in Financial Distress in America

How financially vulnerable are people with medical debt in the U.S.? Significantly more, statistically speaking, we learn from the latest survey data revealed by the National Financial Capabilities Study (NFCS) from the FINRA Foundation. The Kaiser Family Foundation and Peterson Center on Healthcare analyzed the NFCS data through a consumer health care financial lens with a focus on medical debt. Financial distress takes many forms, the first chart inventories. People with medical debt were most likely lack saving for a “rainy day” fund, feel they’re “just getting by” financially, feel their finances control their life, and
Nurses Earn Highest Grade for Care Far Above All Other Health Care Workers — Including Doctors — In Latest Gallup Poll

Nurses rank highest among various factors in the U.S. health system in the latest Gallup poll — earning a grade of “excellent” or “good” by American adults surveyed in November 2023. Further substantiation for nurses’ topping this poll of excellent care is that Gallup found historic low confidence in the U.S. health system among Americans earlier this year in a July study. Note that 8 in 10 consumers rate nurses excellent/good compared with 7 in 10 people ranking physicians this way, 6 in 10 for hospitals, 5 in 10 for telemedicine/virtual visits, and
Inflation and the cost of health care top U.S. voters’ issues for 2024 elections
The cost of living ranks top in U.S. voters’ minds among many issues Americans are feeling and following in late 2023. A close second in line is affordability of health care, as consumers’ household budgets must make room for paying medical bills — with prescription drug costs also very important as a discussion topic for 2024 Presidential candidates, we learn from the latest KFF Health Tracking Poll published 1 December. The monthly study focused on U.S. voters’ top issues and perspectives on the health system and care approaching the new year of 2024. KFF fielded the study among 1,301 U.S.
Healthcare Bills, Affordability, and Self-Rationing Care Will Continue to Challenge U.S. Health Consumers in 2024

Two-thirds of U.S. consumers say they can’t afford to pay their medical bills on-time, based on the 2023 Consumer Survey from Access One, a financial services company focused on healthcare payments. The report’s title page asks the question, “What options do consumers really want for paying healthcare expenses?” The survey report responds to that question, finding out that nearly one-half of patients have taken some kind of action to reduce their medical expenses. Furthermore, one-third of consumers are not confident they could pay a medical bill of $500 or more. Access One fielded
“My Doctor’s Office” Should Accept Wearable Tech Health Data, Most Patients Say

“Do personal health trackers belong in the doctor’s office?” Software Advice wondered. “Yes,” the company’s latest consumer survey found, details of which are discussed in a report published on their website. Unique to this study is the patient sample polled: Software Advice surveyed 876 patients in September 2023 to gauge their perspectives on wearable tech and health. Note that the patient sample was limited to consumers who had seen a health care provider in the past two years and who also owned and used a personal wearable health device such as an Apple Watch or Fitbit. Thus, the responses shared
What Walmart’s Look at Ozempic Users Tells Us About Health/Care Consumers

“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” the CEO of Walmart US is quoted in Bloomberg. “Just less units, slightly less calories.” With patients’ use GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro fast-rising in the pharmacy market, so are the concerns of companies that stock the-middle-of-the-grocery-store aisles for processed foods like sweet and salty snacks. As the prospects for the drug companies who manufacture prescription drugs made for patients managing diabetes and obesity are on the
Food-As-Medicine Grows Its Cred Across the Health/Care and Retail Ecosystem

In the nation’s search for spending smarter on health care, the U.S. could save at least $13 billion a year through deploying medically-tailored meals for people enrolled in Medicare, Medicaid, and private insurance programs, according to the True Cost of Food, research published by the Tufts School of Nutrition Science and Policy collaborating with The Rockefeller Foundation. It’s been one year since the White House convened the Conference on Hunger, Nutrition, and Health, kicking off the Biden Administration’s national strategy to improve health citizens’ access to healthy food as a matter of public health and economic security.
Slip Slidin’ Away: the Reputations of Pharma and Healthcare in the U.S. Decline in the Latest Gallup Poll

Oh, how quickly people forget…and slow to forgive. U.S. consumers’ positive views for healthcare, pharma and retail have significantly fallen in just one year, the latest annual Gallup poll of industry rankings in America found as of August 2023. This stat for the pharma industry was the lowest Gallup ever recorded for the sector since 2001. I can’t help hearing Paul Simon’s lyrics to Slip Slidin’ Away….”you know the nearer your destination, the more you’re slip slidin’ away” when it comes to health citizens’ perceptions of pharma and the healthcare
Hims and Hers and Hearts – Cardiology Blurs Into DTC Retail Health

Statin therapy has been used for decades to lower cholesterol with the goal of reducing mortality and preventing cardiovascular problems such as heart attacks and strokes. Hims & Hers announced a new service offering for health consumers and clinicians concerned about heart health called Heart Health by Hims. This is Hims & Hers’ first foray into cardiovascular health, working in collaboration with the American College of Cardiology (ACC). ACC clinical guidelines will inform the Hims’ provider platform for the program. “Prevention is the ideal mechanism to decrease cardiovascular events and ensure optimal heart
The Doctor Will See You Now…At Home? The AMA Launches a Health at Home Framework

An aging U.S. population with a preference for growing older at home — and a fiscally challenging health care financing outlook — are setting the demographic and financial table for the shift of medical care to peoples’ homes discussed in The State of Health at Home Models: Key Considerations and Opportunities, published by the American Medical Association (AMA). Note that this framework has been developed by the AMA, the largest professional organization of doctors. While moving health care to the home will involve quite different workflows and disruptions to current general medical practice, it
Pharmacy Plays a Growing Role in Consumers’ Health@Retail – J.D. Power’s 2023 Rankings

“Brick-and-mortar pharmacies forge meaningful connections with customers” through conversations between pharmacists and patients, “on a first-name basis.” This quote comes from Christopher Lis, managing director of global healthcare intelligence at J.D. Power who released the company’s annual 2023 U.S. Pharmacy Study today, the 15th year the research has been conducted. Each year, J.D. Power gauges U.S. consumers’ views on retail pharmacies in four channels: brick and mortar chain drug stores, brick and mortar mass merchandisers, brick and mortar supermarkets, and mail order. Across all four channels, the
Cost Trumps Quality of Health Care for Consumers As Their Experience Has Eroded

Patients’ perceptions of health care quality and experience have fallen in the three years since 2020, based on a July 2023 update from The Beryl Institute – Ipsos Px Pulse study. Start with health care quality, which 58% of U.S. adult patients ranked as “very good or good” in June 2020. The percent of health consumers evaluating their healthcare quality as very good or good fell to 41% of people in June 2023, an erosion of 17 percentage points, shown in the first chart. Next, consider patients’ ratings on their care experience,
GNC Offers “Free Healthcare” — Telehealth, Generic Meds, and Loyalty in the Retail Health Ecosystem

The retail health landscape continues to grow, now with GNC Health offering a new program featuring telehealth and “curated set” of 40+ generic prescription drugs commonly used in urgent care settings. The services are available to members of GNC’s new-and-improved loyalty program, GNC PRO Access, which is priced at a fixed fee of $39.99 for one year’s membership. This is available to consumers 18 years of age and older. “As a trusted brand in the health and wellness space, we are thrilled to expand our efforts in helping our customers Live Well by offering
To Avert a GLP-1 Cost Tsunami, Add Lifestyle Interventions: Learning from Virta Health

With consumer and prescriber interest in GLP-1 receptor agonist drugs “soaring,” health plan managers have a new source of financial stress and clinical questions on their to-do list. A team of Virta Health leaders held a webinar on 13th July 2023 to explain the results of a study the company just completed assessing health plan execs’ current views on Ozempic and other GLP-1 medicines with a view on both clinical outcomes and cost implications for this growing category of drugs that address diabetes and obesity. Indeed, diabetes and obesity are top health concerns among the
There’s a New “O” in Medicine-Town – Welcome OPill to the Front of the Counter

You may not be able to get that ear-worm jingle that goes “O O O Ozempic” out of your musical mind, but I’m happy to tell you there’s a new “O” in town: the Opill. Welcome to the first OTC contraceptive for sale in the USA. I wrote about Perrigo’s Opill here in Health Populi in May 2023 as a “signpost on the road to retail health.” It’s official: “The U.S. Food and Drug Administration (FDA) approved Opill®, a progestin-only daily oral contraceptive, for over-the-counter (OTC) use for all ages.
The Cost of Treating Patients is On the Rise: PwC Goes What’s Behind the 2024 Medical Spending Numbers

Health care cost trend will spike up another percentage point to 7.0% in 2024, according to the annual report from the PwC Health Research Institute, Medical cost trend: Behind the numbers 2024. Every year, the PwC HRI team goes behind those numbers to assess cost inflators and deflators which underpin annual medical inflation. As the first line chart illustrates, the peak of medical trend in the last 18 years was in 2007 when the U.S. saw double-digit cost growth of nearly 12%. Here’s a link to PwC’s 2007 study looking behind the
The Latest KFF Poll on Consumer Experiences with Health Insurance Speaks Volumes About Patients’ Administrative Burden

People love being health-insured, but their negative experiences with health plans create serious burdens on patients-as-consumers. And those burdens impact even more people who are unwell than healthier folks. The 2023 Kaiser Family Foundation Survey of Consumer Experiences with Health Insurance updates our understanding of and empathy for insured peoples’ Patient Administrative Burdens (PAB). For this study, KFF polled 3,605 U.S. adults 18 and over in February and March 2023 who had health insurance across different plan types. Over the past several years, I’ve come to appreciate the concept of PAB by listening to and learning from colleagues Dr, Grace
Patients-As-Health Care Payers Define What a Digital Front Door Looks Like

In health care, one of the “gifts” inspired by the coronavirus pandemic was the industry’s fast-pivot and adoption of digital health tools — especially telehealth and more generally the so-called “digital front doors” enabling patients to access medical services and personal work-flows for their care. Two years later, Experian provides a look into The State of Patient Access: 2023. You may know the name Experian as one of the largest credit rating agencies for consumer finance in the U.S. You may not know that the company has a significant footprint
Consumers and Cancer: 3 Patient-Focused Charts From IQVIA on the State of the Oncology in 2023 – and Introducing CancerX

It’s time for the annual ASCO conference, currently convening the American Society for Clinical Oncology in Chicago. Starting 2nd June, there have been dozens of positive announcements updating research and therapies bringing hope to the 2 million new patients who will be diagnosed with cancer in the U.S. in 2023, and millions of more people worldwide. Just in time for #ASCO2023, the IQVIA Institute published their annual report on Global Oncology Trends 2023 – Outlook to 2027, an update featuring pipelines, therapy approvals, research updates, costs of oncology products, and patients.
Our Mental and Emotional Health Are Interwoven With What We Eat and Drink – Chewing On the IFIC 2023 Food and Health Survey

As most Americans confess to feeling stressed over the past six months, peoples’ food and beverage choices have been intimately connected with their mental and emotional well-being, we learn from the 2023 Food & Health Survey from the International Food Information Council (IFIC). For this year’s study, IFIC commissioned Greenwald Research to conduct 1,022 interviews with adults between 18 and 80 years of age in April 2023. The research explored consumers’ perspectives on healthy food, the cost of food, approaches to self-care through food consumption, the growing role of social media in the food system, and the influence of sustainability
Getting Health Care at a Retail Pharmacy vs a Retail Store: Consumers May Be Favoring the Pharmacist Versus the Retailer

Not all “retail health” sites are created equal, U.S. consumers seem to be saying in a new study from Wolters Kluwer Health, the company’s second Pharmacy Next: Consumer Care and Cost Trends survey. Specifically, consumers have begun to differentiate between health care delivered at a retail pharmacy versus care offered at a retail store — such as Target or Walmart (both named as sites that offer “health clinics in department stores” in the study press release). While 58% of Americans were likely to visit a local pharmacy as a “first step” when faced with a non-emergency medical situation and 79%
Three More Signposts on the Road to Retail Health – Weight Loss Drugs, OTC Birth Control and Fashion-Meets-the-Flu

We continue to track to evolving, expanding landscape of retail health — which we see as the expanding ecosystem of health/care accessible to people-as-health consumers. This week, three intriguing examples are resonating with us: The ever-evolving weight-loss industry FDA favors OTC use for Perrigo’s Opill daily oral contraceptive birth control pill The convergence of fashion and health — specifically, how an over-the-counter medicine converges with clothing that helps us feel better. Let’s start with weight-loss, as several aspects of health/care come together in the consumer’s retail health sandbox. Dr. Eric Topol
Thinking Pharma on a Friday: Europe’s Big Reforms for a Health Union & the U.S. 50-State Fragments

The COVID-19 pandemic re-shaped European Union leaders to reimagine healthcare, public health, and health citizenship in the EU. Welcome to #HealthUnion, the hashtag that the European Commission has adopted with the vision of assuring access to medicines for all people living in the 27-nation EU area — regardless of socioeconomic status. On 26th April 2023, the EC unveiled the most significant reforms for the region’s pharmaceutical industry in twenty years. It’s really a package or “toolkit” in the words of EC Health and Food Safety Commissioner Stella Kyriakides for addressing several strategic health pillars
The Patient Is Still the Payor – And May Skip Paying for Prevention (Eyes on the ACA & Texas)

Many health citizens in the U.S. would likely skip receiving preventive health care services if the Affordable Care Act’s (ACA) coverage for them goes away, a Morning Consult survey found. The first chart illustrates the top-line of this research: that most U.S. adults would not pay out of pocket for several preventive services including tobacco cessation, drug use screening, weight loss measures to prevent obesity-related illnesses, as well as screening for depression or HIV. One of the key benefits embedded in the ACA was “free” without co-pay shares for preventive care. These
People Using Health Apps and Wearable Tech Most Likely Track Exercise and Heart Rate, Sleep and Weight – But Cost Is Still A Barrier

Over one in three U.S. consumers use a health app or wearable technology device to track some aspect of their health. “The public’s use of health apps and wearables has increased in recent years but digital health still has room to grow,” a new poll from Morning Consult asserts, published today. Among digital health tech users, most check into them at least once every day in the past month. One in four use these tech’s multiple times a day, the first pie chart illustrates. Eighteen percent of people use their digital
Quick, Accessible, Inexpensive Health Care – A Retail Health Update from Amazon and Dollar General

Two announcements this week add important initiatives to patients’ growing choices that speak to their consumer-sides’ sense of value and personal healthcare cost-containment: Amazon launched RxPass, a generic medicines subscription service; and, Dollar General promoted its mobile health service powered by DocGo on demand for health visits, “right outside the store.” These two programs come from outside of the legacy health care system of so-called incumbents — hospitals, health systems, health insurance — leveraging two brand-names beloved to many consumers for convenience, price transparency, and sheer cost. First, check out Amazon Pharmacy’s RxPass. Amazon
When Household Economics Blur with Health, Technology and Trust – Health Populi’s 2023 TrendCast

People are sick of being sick, the New York Times tells us. “Which virus is it?” the title of the article updating the winter 2022-23 sick-season asked. Entering 2023, U.S. health citizens face physical, financial, and mental health challenges of a syndemic, inflation, and stress – all of which will shape peoples’ demand side for health care and digital technology, and a supply side of providers challenged by tech-enabled organizations with design and data chops. Start with pandemic ennui The universal state of well-being among us mere humans is pandemic ennui: call it languishing (as opposed to flourishing), burnout, or
Consumers Are Feeling Their Healthcare Cost of Living – Research from Qualtrics

Rising costs are the #1 reason U.S. health consumers are avoiding or delaying health care, replacing concerns about COVID-19, based on survey research from Qualtrics. The company’s Healthcare Cost of Living survey research learned that 48% of U.S. adults chose to defer health care in 2022, split by 31% of consumers skipping care due to cost concerns, and, 17% of people delaying care who had concerns about the coronavirus. Note the types of care delayed or skipped: Over 27% of people delayed care related to nutrition 26% delayed routine or preventive care, such as screenings or
Consumers Rank Healthcare Experiences in the Bottom-Third of All Industries – the ACSI 2021-2022 Index

While consumers’ satisfaction with inpatient care experiences improved a few points over the past year, health insurance and hospitals still fall in the bottom-third of all industries with which people interact, according to the American Customer Satisfaction Index (ACSI) Insurance and Health Care Study 2021-2022. “With visitor restrictions relaxing and more elective procedures going forward, hospitals are slowly coming out of a COVID-induced satisfaction slump,” the study press released quoted Forrest Morgeson, Assistant Professor of Marketing at Michigan State University. This year’s ACSI Insurance and Health Care Index was developed through 12,840 consumer interviews
$22,463 Can Get You a Year of College in Connecticut, a Round of Ref Work in the Stanley Cup Playoffs, or Health Benefits for a Worker’s Family

Employers covering health insurance for workers’ families will face insurance premiums reaching, on average, $22,463. That is roughly what a year at an independent college in Connecticut would cost, or a round of pay for a ref in the Stanley Cup playoffs. With that sticker-shock level of health plan costs, welcome to the 2022 Employer Health Benefits Survey from Kaiser Family Foundation, KFF’s annual study of employer-sponsored health care. Each year, KFF assembles data we use all year long for strategic and tactical planning in U.S. health care. This mega-study looks at
Consumers’ Trust In Pharmacists As Providers Grows Along with Omnichannel Health Care

What is a “pharmacy” these days? You might have recently walked into a brick-and-mortar retail pharmacy. Or, you might have refilled a prescription to help you manage a chronic condition, online. Or, perhaps, you asked the pharmacist staffing your favorite grocery store Rx counter to give you the latest vaccine to keep COVID-19 variants at-bay. The pharmacy is all these things, and increasingly digital-first, we learn in The Rx Report: A new day in retail pharmacy, a consumer survey from CVS Health. CVS Health, one of the two largest pharmacies operating in the U.S. in 2021
How Will the “New” Health Economy Fare in a Macro-Economic Downturn?

What happens to a health care ecosystem when the volume of patients and revenues they generate decline? Add to that scenario a growing consensus for a likely recession in 2023. How would that further impact the micro-economy of health care? A report from Trilliant on the 2022 Trends Shaping the Health Economy helps to inform our response to that question. Start with Sanjula Jain’s bottom-line: that every health care stakeholder will be impacted by reduced yield. That’s the fewer patients, less revenue prediction, based on Trilliant’s 13 trends re-shaping the U.S. health
Health in the 2022 U.S. Midterm Elections – Women, Prescription Drugs, and Who Shows Up to Vote

On Tuesday November 8, 2022, health and medical issues will be on many U.S. voters’ minds as they enter voting booths to select representatives for the House and the Senate, along with some states’ ballots addressing specific healthcare issues. Health policy experts from Manatt, Phelps & Phillips, AARP, and the United States of Care recently shared perspectives on the health care issues on voters’ and policy makers’ minds for the 2022 midterm elections. This post synthesizes their analyses as we lead up to what will be a pivotal election for Americans’ public health, individual well-being, and access to care.
The Patient as Prescription Drug Payer – The GoodRx Playbook

Patients have more financial skin-in-their-healthcare-games facing high-deductibles and direct out-of-pocket costs for medical bills…including prescription drugs. I collaborated with GoodRx on a “yellow paper” discussing The Health Consumers as Payer, with implications and calls-to-action for pharma and life science companies. You can download the paper at this link. The report is intended to be a playbook for understanding patients’ growing role as consumers and health care payers, providing insights into peoples’ home economic mindsets and how these impact a patient’s adherence to medication based on cost and perceived value. With inflation facing household





Hackathons are intense, fast-paced events where interdisciplinary teams come together to solve complex problems. In this SEE YOU NOW Insight from
I'm once again pretty gobsmackingly happy to have been named a judge for
Stay tuned to Health Populi in early January as I'll be attending Media Days and meeting with innovators in digital health, longevity, and the home-for-health during